| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Altimmune, Inc. | Chief Financial Officer | Common Stock, par value $0.0001 | 45,012 | $441,118 | $9.80 | 31 Jan 2024 | Direct |
| Altimmune, Inc. | Chief Financial Officer | Stock Options (option to buy) | 163,200 | 25 Jan 2024 | Direct | ||
| Altimmune, Inc. | Chief Financial Officer | Restricted Stock Units | 27,825 | 30 Jan 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ALT | Altimmune, Inc. | 30 Jan 2024 | 4 | -$8,885 | 4 | Chief Financial Officer | 01 Feb 2024, 18:00 |
| ALT | Altimmune, Inc. | 25 Jan 2024 | 2 | $0 | 4 | Chief Financial Officer | 29 Jan 2024, 18:30 |
| ALT | Altimmune, Inc. | 29 Dec 2023 | 3 | -$34,245 | 4 | Chief Financial Officer | 02 Jan 2024, 18:00 |
| ALT | Altimmune, Inc. | 31 Jul 2023 | 1 | +$5,128 | 4 | Chief Financial Officer | 02 Aug 2023, 17:51 |
| ALT | Altimmune, Inc. | 24 Mar 2023 | 1 | +$43,140 | 4 | Chief Financial Officer | 24 Mar 2023, 20:54 |
| ALT | Altimmune, Inc. | 31 Jan 2023 | 1 | +$11,964 | 4 | Chief Financial Officer | 02 Feb 2023, 16:09 |
| ALT | Altimmune, Inc. | 30 Jan 2023 | 2 | $0 | 4 | Chief Financial Officer | 01 Feb 2023, 16:31 |
| ALT | Altimmune, Inc. | 31 Dec 2022 | 3 | -$49,811 | 4 | Chief Financial Officer | 03 Jan 2023, 16:59 |
| ALT | Altimmune, Inc. | 31 Jul 2022 | 1 | +$9,371 | 4 | Chief Financial Officer | 03 Aug 2022, 16:05 |
| ALT | Altimmune, Inc. | 31 Dec 2021 | 2 | $0 | 4 | Chief Financial Officer | 04 Jan 2022, 05:11 |
| ALT | Altimmune, Inc. | 31 Dec 2021 | 0 | $0 | 3 | Chief Financial Officer | 04 Jan 2022, 05:07 |